# LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus

> **NCT00423215** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 1007 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin glargine (LANTUS)

## Key facts

- **NCT ID:** NCT00423215
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 1007 (ACTUAL)
- **Last updated:** 2009-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423215, "LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00423215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*